BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 8588642)

  • 1. Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in a patient with neurofibromatosis type 2.
    Black FO; Brackmann DE; Hitselberger WE; Purdy J
    Am J Otol; 1995 Jul; 16(4):431-43. PubMed ID: 8588642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in building a management algorithm for vestibular schwannomas.
    Doherty JK; Friedman RA
    Curr Opin Otolaryngol Head Neck Surg; 2006 Oct; 14(5):305-13. PubMed ID: 16974142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2.
    Kuo YH; Roos D; Brophy BP
    J Clin Neurosci; 2008 Jul; 15(7):744-8. PubMed ID: 18403208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
    Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
    Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome from surgery for vestibular schwannomas in children.
    MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
    Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
    Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
    Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.
    Slattery WH; Fisher LM; Hitselberger W; Friedman RA; Brackmann DE
    J Neurosurg; 2007 Apr; 106(4 Suppl):255-60. PubMed ID: 17465357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory brainstem implants for neurofibromatosis type 2.
    Colletti L; Shannon R; Colletti V
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
    Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis 2: two case reports.
    Drsata J; Celakovský P; Vokurka J; Lánský M
    Int Tinnitus J; 2003; 9(2):116-8. PubMed ID: 15106286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial nerve function and hearing preservation after retrosigmoid excision of vestibular schwannoma: Christchurch Hospital experience with 97 patients.
    Darwish BS; Bird PA; Goodisson DW; Bonkowski JA; MacFarlane MR
    ANZ J Surg; 2005 Oct; 75(10):893-6. PubMed ID: 16176235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of intracochlear schwannomas.
    Grayeli AB; Fond C; Kalamarides M; Bouccara D; Cazals-Hatem D; Cyna-Gorse F; Sterkers O
    Otol Neurotol; 2007 Oct; 28(7):951-7. PubMed ID: 17728691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
    Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
    J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
    Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
    Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.